Clinical Trials Directory

Trials / Completed

CompletedNCT03860402

The Effect of Warm Local Anesthetic Solution on Epidural Anesthesia

The Effect of Warm Local Anesthetic Solution for Sensory Block on Epidural Anesthesia of Cesarean Delivery : a Randomized Controlled Study

Status
Completed
Phase
Study type
Observational
Enrollment
50 (actual)
Sponsor
Hallym University Kangnam Sacred Heart Hospital · Academic / Other
Sex
Female
Age
20 Years – 45 Years
Healthy volunteers
Accepted

Summary

The investigators are going to compare the onset and duration of nerve blockage with the use of pre-warmed (38°C) and room temperature (20°C) local anesthetic solutions (ropivacaine and fentanyl) on epidural anesthesia for cesarean section, and compare the incidence of complications such as hypotension, nausea and vomiting.

Detailed description

Spinal anesthesia has a shorter time to onset than epidural anesthesia, and the amount of local anesthetic administered is lower than that of epidural anesthesia, resulting in less systemic toxicity and superior block effect. However, there are disadvantage that it is difficult to control the block height and the incidence of hypotension is high. On the other hand, epidural anesthesia has the advantages of less sudden hypotension due to slow autonomic blockade, but it has a disadvantage that sensory nerve and motor nerve block time is delayed compared to spinal anesthesia. The degree of nerve block for cesarean section surgery requires a high level of anesthesia above the T6 level, so the frequency of hypotension is high due to rapid sympathetic block after spinal anesthesia. In this respect, hemodynamically stable epidural anesthesia is preferred when performing anesthesia for cesarean section. The investigators are going to compare the onset and duration of nerve blockage with the use of pre-warmed (38°C) and room temperature (20°C) local anesthetic solutions (ropivacaine and fentanyl) on epidural anesthesia for cesarean section, and compare the incidence of complications such as hypotension, nausea and vomiting.

Conditions

Interventions

TypeNameDescription
OTHERTemperaturetemperature of drug

Timeline

Start date
2019-02-01
Primary completion
2019-12-31
Completion
2020-01-31
First posted
2019-03-01
Last updated
2020-03-06

Locations

1 site across 1 country: South Korea

Source: ClinicalTrials.gov record NCT03860402. Inclusion in this directory is not an endorsement.